(Repealed by Act 21 of 1994)
CHAPTER 245
DANGEROUS DRUGS ACT
Commencement Date: 1933-02-01
An Act of Parliament to regulate the importation, exportation,
manufacture, sale and use of opium and other dangerous drugs
PART I - PRELIMINARY
Short title.
1. This Act may be cited as the Dangerous Drugs Act.
Interpretation.
2. In this Act, except where the context otherwise requires "coca leaves" means the leaves of any plant of the genus of the Erythroxylaceae
from which cocaine can be extracted either directly or by chemical transformation;
"the Geneva Convention (No. 1)" means the convention signed at Geneva on the
19th February, 1925, for the purpose of completing and strengthening the provisions
of the Hague Convention;
"the Geneva Convention (No. 2)" means the convention signed at Geneva on the
13th July, 1931, for limiting the manufacture and regulating the distribution of
narcotic drugs;
"the Hague Convention" means the International Convention signed at The Hague on
the 23rd January, 1912;
"Indian hemp" means the dried flowering or fruiting tops of the pistillate plant known
as cannabis sativa from which the resin has not been extracted, by whatever name
such tops are called;
"medicinal opium" means raw opium which has undergone the processes necessary
to adapt it for medicinal use in accordance with the requirements of the British
Pharmacopoeia, whether it is in the form of powder or is granulated or is in any
other form, and whether it is or is not mixed with neutral materials;
"prepared opium" means opium prepared for smoking, and includes dross and any
other residues remaining after opium has been smoked, and also includes any
opium, for whatever purpose prepared, which is capable of being smoked;
"raw opium" includes powdered or granulated opium, but does not include medicinal
opium.
PART II - RAW OPIUM AND COCA LEAVES
2
Cap. 245
Dangerous Drugs
[Rev. 1983
Restriction of import and export of raw opium and coca leaves
L.N.187/1956,
L.N.172/1960.
3. (1) No person shall import or export raw opium or coca leaves except
under licence and into or from prescribed ports or places.
(2) If at any time the importation of raw opium or coca leaves into a foreign country
is prohibited or restricted by the laws of that country, there shall, while that
prohibition or restriction; is in force, be attached to every licence which is issued
under this Act authorizing the export of raw opium or coca leaves from Kenya such
conditions as may appear to the licensing officer to be necessary for preventing or
restricting, as the case may be, the exportation of raw opium or coca leaves from
Kenya to that country during such time as the importation of raw opium or coca
leaves into that country is so prohibited or restricted, and any such licences issued
before the prohibition or restriction came into force shall, if the Minister by order so
directs, be deemed to be subject to the same conditions.
Power to regulate production of and dealing in raw opium and coca leaves.
L.N.188/1956,
L.N.173/1960.
4. The Minister may make rules for controlling or restricting the production,
possession, sale and distribution of raw opium or coca leaves, and in particular, but
without prejudice to the generality of the foregoing power, for prohibiting the
production, possession, sale or distribution of raw opium or coca leaves except by
persons licensed or otherwise authorized in that behalf, and for controlling or
restricting the possession of or dealing in raw opium or coca leaves while in transit
through Kenya, whether by land, by air or by water.
Prohibition of trade, etc., in new drugs, and power to apply Part V to certain
drugs. L.N.187/1956,
L.N.172/1960.
5.(1) No person shall in Kenya trade in or manufacture for the purpose of
trade any products obtained from any of the phenanthrene alkaloids of opium or
from the ecgonine alkaloids of the coca leaf, not being a product which was on the
13th July, 1931, being used for medical or scientific purposes:
Provided that, if the Minister is at any time satisfied as respects any such product
that it is of medical or scientific value, he may by order direct that this subsection
shall cease to apply to that product.
(2) If it is made to appear to the Minister that a decision with respect to any such
product as is mentioned in subsection (1) has in pursuance of Article 11 of the
Geneva Convention (No 2) been communicated to the parties to that Convention, the
Minister, by order, may, as the case requires, either declare that the provisions of
Part V of this Act shall apply to that product in the same manner as they apply to the
drugs mentioned in subsection (1) of section 14 or apply Part V to that product with
such modifications as may be specified in the order.
(3) The Minister may by order apply Part V, with such modifications as may be
specified in the order, to methylmorphine (commonly known as codeine),
ethylmorphine (commonly known as dionin) and their respective salts.
Prohibition of cultivation of opium or coca plant.
Rev. 1983]
Dangerous Drugs
Cap. 245
3
6. No person shall cultivate the opium poppy (papaver somniferum) or the
coca plant (Erythroxylum coca).
PART III - PREPARED OPIUM
Prohibition of export and import of prepared opium.
7. No. person shall import or export prepared opium.
Penalty for manufacturing. selling, using, etc., prepared opium.
8. A person who (a) manufactures, sells or otherwise deals in prepared opium; or
(b) has in his possession any prepared opium; or
(c) being the occupier of premises, permits those premises to be used for the
purpose of the preparation of opium for smoking or the sale or smoking of prepared
opium; or
(d) is concerned in the management of premises used for any such purpose; or
(e) has in his possession any pipes or other utensils for use in connexion with the
smoking of opium, or any utensils used in connexion with the preparation of opium
for smoking; or
(f) smokes or otherwise uses prepared opium, or frequents a place used for the
purpose of opium smoking,
shall be guilty of an offence.
PART IV - INDIAN HEMP
Prohibition of import and export of Indian hemp and resin from plant
cannabis sativa.
9. No person shall import or export Indian hemp, or any resin obtained from
the plant cannabis sativa, or any products of which that resin forms the base
(excluding such products which are used solely for medicinal purposes):
Provided that where Indian hemp, resin or products are imported solely for the
purpose of transit (including deviation) through Kenya, or are exported immediately
after having been imported for that purpose, the goods shall not be deemed to have
been imported or exported within the meaning of this section.
Offences respecting plant cannabis sativa and resin therefrom.
10. A person who (a) produces, sells or otherwise deals in Indian hemp, or resin obtained from the
plant cannabis saliva, or any products of which that resin forms the base; or
(b) has in his possession any Indian hemp, or any resin from the plant cannabis
sativa, or any products of which that resin forms the base, except when the Indian
hemp, resin or products are in transit through Kenya, whether by land, by air or by
water; or
4
Cap. 245
Dangerous Drugs
[Rev. 1983
(c) cultivates the plant cannabis sativa: or
(d) sells or otherwise deals in the whole or any portion of the plant cannabis sativa
(excluding its medicinal preparations); or
(e) has in his possession the whole or any portion of the plant cannabis sativa
(excluding its medicinal preparations),
shall be guilty of an offence.
Rules respecting Indian hemp and resin from plant cannabis sativa in transit
through Kenya.
L.N.188/1956,
L.N.173/1960.
11. The Minister may make rules for controlling or restricting the possession
of or dealing in Indian hemp, or resin obtained from the plantcannabissativa, or
products of which that resin forms the base, while the Indian hemp, resin or
products is or are in transit through Kenya, whether by land, by air or by water.
PART V - COCAINE, MORPHINE, ETC.
Restriction on import and export of cocaine, etc.
12. No person shall import or export a drug to which this Part applies, except
under licence, and into or from prescribed ports or places.
Rules for control of cocaine, etc.
L.N.188/1956,
L.N.173/1960,
L.N.3/1962.
Cap. 244.
13.(1) For the purpose of preventing the improper use of the drugs to which
this Part applies, the Minister may make rules for controlling the manufacture, sale,
possession and distribution of those drugs, and in particular, but without prejudice to
the generality of the foregoing, for (a) prohibiting the manufacture of a drug to which this Part applies except on
premises licensed for the purpose and subject to conditions specified in the licence;
and
(b) prohibiting the manufacture, sale or distribution of any such drug except by
persons licensed or otherwise authorized under rules made under this Act and
subject to any conditions specified in the licence or authority; and
(c) regulating the issue by medical practitioners of prescriptions containing any such
drug and the dispensing of any such prescriptions; and
(d) requiring persons engaged in the manufacture, sale or distribution of any such
drug to keep such books and furnish such information either in writing or otherwise
as may be prescribed; and
(e) controlling or restricting the possession of or dealing in any such drug while in
transit through Kenya, whether by land, by air or by water.
Rev. 1983]
Dangerous Drugs
Cap. 245
5
(2) Rules under this section shall provide for authorizing a person who lawfully keeps
open shop for the retailing of poisons in accordance with the Pharmacy and Poisons
Act;
(a) to manufacture at the shop in the ordinary course of his retail business any
preparation, admixture or extract of any drug to which this Part applies; or
(b) to carry on at the shop the business of retailing, dispensing or compounding any
such drug,
subject to the power of the Minister to withdraw the authorization in the case of a
person who has been convicted of an offence under this Act or rules made
thereunder and who cannot, in the opinion of the Minister, properly be allowed to
carry on the business of manufacturing or selling or distributing, as the case may be,
any such drug.
(3) Nothing in rules made under this section shall be taken to authorize the sale, or
the keeping of an open shop for the retailing, dispensing or compounding, of poisons
by a person who is not qualified in that behalf under, or otherwise than in
accordance with, the Pharmacy and Poisons Act, or to be in derogation of the
provisions of that Act for prohibiting, restricting or regulating the sale of poisons.
Drugs to which Part applies.
L.N.188/1956,
L.N.173/1960.
14.(1) The drugs to which this Part applies are (a) medicinal opium;
(b) an extract or tincture of Indian hemp;
(c) morphine and its salts, and diacetylmorphine (commonly known as diamorphine
or heroin) and other esters of morphine and their respective salts;
(d) Cocaine(including synthetic coccaine) and ecgonine and their respective salts,
and the esters of ecgonine and their respective salts;
(e) a solution or dilution of morphine or cocaine or their salts in an inert substance
whether liquid or solid, containing a proportion of morphine or cocaine, and a
preparation, admixture, extract or other substance (not being such a solution or
dilution as aforesaid) containing not less than one-fifth per centum of morphine or
one-tenth per centum of cocaine or of ecgonine;
(f) a preparation, admixture, extract or other substance containing a proportion of
diacetylmorphine;
(g) dihydrohydroxycodeinone, dihydrocodeinone, dihydromorphinone,
acetyldihydrocodeinone, dihydromorphine, their esters and the salts of any of these
substances and of their esters, morphine-N-oxide (commonly known as
genomorphine), the morphine- N-oxide derivatives, and any other pentavalent
nitrogen morphine derivatives;
6
Cap. 245
Dangerous Drugs
[Rev. 1983
(h) thebaine and its salts, and (with the exception of methylmorphine, commonly
known as codeine, and ethylmorphine, commonly known as dionin, and their
respective salts) benzylmorphine and the other ethers of morphine and their
respective salts;
(i) a preparation, admixture, extract or other substance containing a proportion of
any of the substances mentioned in, paragraph (g) or (h).
(2) For the purposes of subsection (1) "ecgonine" means laevo-ecgonine, and
includes derivatives of ecgonine from which it may be recovered industrially, and the
percentage in the case of morphine shall be calculated as in respect of anhydrous
morphine.
(3) For the purposes of this section percentages in the case of liquid preparations
shall, unless other provision in that behalf is made by rules made under this Act, be
calculated on the basis that a preparation containing one per centum of any
substance means a preparation in which one gramme of the substance, if a solid, or
one millilitre of the substance, if a liquid, is contained in every hundred millilitres of
the preparation, and so in proportion, for any greater or less percentage.
(4) If it appears to the Minister that any new derivative of morphine or cocaine or of
any salts of morphine or cocaine or any other alkaloid of opium or any other drug of
whatever kind is or is likely if improperly used to be productive, or is capable of
being converted into a substance which is or is likely if improperly used to be
productive, of ill-effects substantially of the same character or nature as or
analogous to those produced by morphine or cocaine, the Minister may by order
provide that this Part shall apply to that new derivative or alkaloid or other drug in
the same manner as it applies to the drugs mentioned in subsection (1).
(5) If the Minister thinks fit to declare that a finding with respect to a preparation
containing any of the drugs to which this Part applies has in pursuance of Article 8 of
the Geneva Convention (No. 1) been communicated to the parties to that
Convention, the provisions of this Part shall, as from the date specified in the
declaration, cease to apply to the preparations specified therein.
PART VI - GENERAL
Licences.
L.N.188/1956
L.N.173/1960
15. Licences, permits or authorities for the purposes of this Act may be
issued or granted by such person on such terms and subject to such conditions
(including in the case of a licence the payment of a fee) as the Minister may
prescribe.
Exporter or agent liable for contravention regarding export.
16. If any goods prohibited to be exported by virtue of this Act or rules made
thereunder are exported in contravention thereof, or brought to a quay or other
place to be shipped for the purpose of being so exported or of being waterborne to
be so exported, the exporter or his agent shall be guilty of an offence.
Powers of inspection and seizure.
17.(1) A police officer or other person authorized in seizure, that behalf by a
general or special order of the Commissioner of Police, of the Director of Medical
Rev. 1983]
Dangerous Drugs
Cap. 245
7
Services or of a Provincial Commissioner may, for the purposes of the execution of
this Act, enter the premises of a person carrying on the business of; a producer,
manufacturer, seller or distributor of drugs to which this Act applies, and demand the
production of and inspect books or documents relating to dealings in any such drugs,
and to inspect stocks of any such drugs.
(2) If a magistrate is satisfied by information on oath that there is reasonable ground
for suspecting that(a) drugs to which this Act applies are, in contravention of the provisions of this Act
or rules made thereunder, in the possession or under the control of any person in
any premises; or
(b) a document directly or indirectly relating to or connected with a transaction or
dealing which was, or an intended transaction or dealing which would if carried out
be, an offence under this Act or rules made thereunder or, in the case of a
transaction or dealing carried out or intended to be carried out in a place outside
Kenya, an offence under any corresponding law in force in that place is in the
possession or under the control of any person in any premises,
he may grant a search warrant authorizing a police officer named in the warrant, at
any time or times within one month from the date of the warrant, to enter, if need
be by force, the premises named in the warrant, and to search the premises and any
persons found therein, and if there is reasonable ground for suspecting that an
offence under this Act or rules made thereunder has been committed in relation to
any such drugs which may be found in the premises or in possession of any such
persons, or that any document which may be so found is a document as aforesaid, to
seize and detain those drugs or that document, as the case may be.
(3) If it appears to a police officer that delay occasioned by obtaining a search
warrant will defeat the objects of this section, he may exercise the powers conferred
by subsection (2) as if he were in possession of a search warrant, but he shall as
soon as possible report what he has done to a magistrate.
(3) A person who wilfully delays or obstructs a person in the exercise of his powers
under this section, or fails to produce or conceals or attempts to conceal any such
books, stocks, drugs or documents, shall be guilty of an offence.
Offences and penalties
25 of 1968, Sch.,
4 of 1974, Sch.,
19 of 1982,Sch.
18. (1) A person who (a) acts in contravention of, or fails to comply with, any provision of this Act or of
rules made under section 4 or section 13;or
(b) acts in contravention of, or fails to comply with, the conditions of a licence or
permit issued or authority granted under or in pursuance of this Act or rules made
thereunder; or
(c) for the purpose of obtaining, whether for himself or for another person, the issue,
grant or renewal of any such licence, permit or authority, makes a declaration or
8
Cap. 245
Dangerous Drugs
[Rev. 1983
statement which is false in any particular, or knowingly utters, produces or makes
use of any such declaration or statement or any document containing it; or
(d) in Kenya aids, abets, counsels or procures the commission outside Kenya of an
offence punishable under a corresponding law in force in that place, or does an act
preparatory to, or in furtherance of an act which if committed in Kenya would
constitute an offence under this Act or rules made thereunder,
shall be guilty of an offence.
(2) A person who is guilty of an offence under this Act or rules made thereunder
shall be liable to a fine not exceeding twenty thousand shillings, or to imprisonment
for a term not exceeding ten years, or to both.
(3) No person shall, on conviction for an offence of contravening or failing to comply
with any rule under this Act once relating to the keeping of books or the issuing or
dispensing of prescriptions containing drugs to which this Act applies, be sentenced
to imprisonment without the option of a fine or to a fine exceeding one thousand
shillings, if the court dealing with the case is satisfied that the offence was
committed through inadvertence and was not preparatory to, or committed in the
course of, or in connexion with, the commission or intended commission of another
offence under this Act or rules made thereunder.
(4) If a person attempts to commit an offence under this Act or rules made
thereunder, or solicits or incites another person to commit such an offence, he shall
be guilty of an offence and, without prejudice to any other liability, liable to the
punishment and forfeiture as if he had committed the offence attempted.
(5) Where a person convicted of an offence under this Act or under any rules made
thereunder is a company, the chairman and every director and every officer
concerned in the management of the company shall be guilty of the offence, unless
he proves that the act constituting the offence took place without his knowledge or
consent.
(6) An offence under this Act shall be triable by any subordinate court.
Definition of "corresponding law".
19. In sections 17 and 18 "corresponding law" means a law stated in a
certificate purporting to be issued by or on behalf of the government of a country
outside Kenya to be a law providing for the control and regulation in that country of
the manufacture, sale, use, export and import of drugs in accordance with the Hague
Convention, the Geneva Convention (No.1) or the Geneva Convention (No.2) and a
statement in any such certificate as to the effect of the law mentioned in the
certificate, or a statement in any such certificate that any facts constitute an offence
against that law shall be conclusive.
Power of arrest.
20. A police officer or medical officer in the service of the Government may
arrest without warrant a person who has committed, or attempted to commit, or is
reasonably suspected by the officer of having committed or attempted to commit, an
offence under this Act or rules made thereunder, if he has reasonable ground for
believing that that person will abscond unless arrested, or if the name and address of
that person are unknown to and cannot be ascertained by him.
Rev. 1983]
Dangerous Drugs
Cap. 245
9
Meaning of importation and exportation under licence.
21.For the purposes of this Act an article shall be deemed to be imported
under licence or exported under licence if the importer or exporter is the holder of a
licence issued under this Act authorizing the importation or exportation of the article
and complies with the conditions of the licence, but not otherwise.
Burden of proof.
22. In proceedings against a person for an offence Burden of proof under this
Act or rules made thereunder, it shall not be necessary to negative by evidence a
licence, authority or other matter of exception or defence, and the burden of proving
any such matter shall lie on the person seeking to avail himself thereof.
Rules.
L.N.188/1956.
L.N.173/1960,
L.N.690/1961.
23. The Minister may make rules (a) providing for the forms of declarations, certificates or permits made or issued for
the purposes of this Act and the conditions (if any) to be contained therein;
(b) prescribing the hours within which and the manner in which a declaration of a
drug to which this Act applies shall be made by the master or person in charge of a
ship or other conveyance;
(c) regulating the arrival and berthing of ships or aircraft carrying a drug to which
this Act applies;
(d) providing for the rendering of periodical returns by a person being in possession
of or producing or manufacturing a drug to which this Act applies within Kenya, and
for the rendering by a person of an estimate of the amount of any such drug to be
imported by him during a period to be prescribed by the rules, to such officer as the
Minister shall appoint in that behalf;
(e) generally for the better carrying out of the objects and purposes of this Act.
Rewards.
24. Where, on conviction for an offence under this Act or rules made
thereunder, a fine is imposed, the court may award an amount, not exceeding four
hundred shillings, of the fine recovered as a reward to a person (not being a person
whose duty it is to detect or assist in the detection of such offences) who gave
information leading to the conviction.
10
Cap. 245
Dangerous Drugs
[Rev. 1983
SUBSIDIARY LEGISLATION
Orders under section 5 (1) proviso
THE DANGEROUS DRUGS (RELAXATION) ORDER
1. This Order may be cited as the Dangerous Drugs (Relaxation) Order.
2. Section 5 (1) of the Act shall cease to apply to the drugs N-Allylnormorphine and
Morpholinylothylmorphine.
Rules under sections 13 (1) and 23
THE DANGEROUS DRUGS RULES
ARRANGEMENT OF RULES
Cap. 129 (1948),
Sub. Leg.
G.N. 1027/1951.
L.N. 140/1959
L.N. 755/1961
L.N. 151/1968
PART 1 – PRELIMINARY
Rule
1—Citation.
2—Application.
3—Interpretation.
PART II—MANUFACTURE, SALE, DISTRIBUTION AND POSSESSION OF COCAINE, MORPHINE
ETC.
4—Manufacture under licence only.
5—Restrition on supply and procuring of drugs.
6—Further restrictions on distribution except where medically prescribed.
7—Prescriptions.
8—Dispensing of prescriptions.
9—Conditions of prossession.
10—Marking of packages or bottles.
11—Registers to be kept by persons supplying.
12—Alternative to keeping register.
13—Meaning of “proper reference”.
14—Inspection of registers.
15—Seller of poisons may manufacture, etc., in certain cases.
16—Medical practitioner, etc., may possess and supply drugs in certain cases.
17—Withdrawal of authority.
18—Delivery to messengers.
19—When drugs in possession of person.
20—Power to exempt hospitals, etc.
21—Exemption of certain preparations.
22—Preservation of records.
PART III-CONTROL OF EXTERNAL TRADE
23—Interpretation of part.
24—Export of dangerous drugs.
25—Import of dangerous drugs.
Rev. 1983]
Dangerous Drugs
Cap. 245
11
26—Dangerous drugs in transit
27—Removal licence.
28—Drugs not to be tampered with.
29—Diversion of dangerous drugs.
30—Periodical returns.
31—Drugs to be imported or exported only through appointed ports.
SCHEDULES
Citation.
1. These Rules may be cited as the Dangerous Drugs Rules.
Application.
2. The dangerous drugs to which these Rules apply are those to which Part V of the Act
applies, and “drug” and “dangerous drug” shall be construed accordingly.
Interpretation.
Cap. 253.
Cap. 366
3. In these Rules, except where the context otherwise requires—
“dentist” means a person for the time being registered or licensed as a dentist under the
Medical Practitioners and Dentists Act;
“veterinary surgeon” means a person for the time being registered or licensed as a veterinary
surgeon under the Veterinary Surgeons Act.
PART II—MANUFACTURE, SALE, DISTRIBUTION AND POSSESSION OF COCAINE, MORPHINE,
ETC.
Manufacture under licence only.
4. No person shall manufacture or carry on any process in the manufacture of drugs—
(a) unless he is licensed by the Director of Medical Services or is authorized by this Part or by
an authority granted by the Director of Medical Services to do so;
(b) except on premises licensed for the purpose by the Director of Medical Services;
(c) otherwise than in accordance with the terms and conditions of the licence or authority.
Restriction on supply and procuring of drugs.
5. No person shall supply or procure, drugs to or for any (including himself) and whether of in
Kenya or elsewhere, or advertise drugs for sale—
(a) unless he is licensed by the Director of Medical Services or is authorized by this Part or by
an authority granted by the Director of Medical Services to supply the drugs, or unless he is
licensed by the Director of Medical Services to import or export the drugs, or unless he is
licensed or otherwise authorized to manufacture the drugs, or (but so far only as regards
procuring) unless he is licensed to procure them;
(b) otherwise than in accordance with the terms and conditions of the licence or authority.
Further restrictions on distribution except when medically prescribed.
6. (1) Except when drugs are lawfully dispensed in pursuance of a prescription given by a
medical practitioner, dentist or veterinary surgeon, or are supplied by a medical practitioner or
veterinary surgeon who dispenses his own medicines in accordance with the conditions
specified in this Part, no person shall supply or procure, or offer to supply or procure, any of
the drugs to or for a person in Kenya who is not licensed or otherwise authorized to be in
12
Cap. 245
Dangerous Drugs
[Rev. 1983
possession of the drug nor to a person so licensed or authorized except in accordance with the
terms and conditions of a licence or authority.
(2) The administration of a drug by or under the direct personal supervision of a medical
practitioner, or dentist in dental treatment, or by or under the direct personal supervision of a
veterinary surgeon in the treatment of an animal, shall not be deemed to be supplying the
drug within the meaning of this Part.
Prescriptions.
7. A prescription for the supply of drugs shall comply with the Prescriptions following
conditions—
(a) the prescription shall be iii writing, and shall be dated and signed by the person giving it,
with his address, the name and address of the person for whose use it is given and the total
amount of the drug to be supplied on the prescription;
(b) a prescription shall only be given by a medical practitioner when required for the purposes
of medical treatment;
(c) a prescription shall only be given by a dentist for the purposes of dental treatment, and
shall be marked “For local dental treatment only;
(d) a prescription shall only be given by a veterinary surgeon for the purposes of treatment of
animals, and shall be marked “For animal treatment only”;
(e) the Director of Medical Services may lay down and issue a form (in this Part referred to as
the official form) for use in giving prescriptions for drugs; and in that case a prescription shall
be given on the official form; but in a case of emergency when the person giving the
prescription has not the official form available, the prescription may be given without using the
official form, and in that case it shall be marked with the words “Official form not available” or
with similar words;
(f) a medical practitioner, dentist or veterinary surgeon shall not give a prescription for the
supply of drugs otherwise than in accordance with the conditions set out in this Part;
(g) a medical practitioner, dentist or veterinary surgeon who dispense drugs shall enter
particulars thereof in his day book or in the register hereinafter specified.
Dispensing of prescriptions.
8. The following conditions shaft be observed by persons dispensing prescriptions for drugs—
(a) if the official form is laid down and issued by the Director of Medical Services in pursuance
of rule 7, a prescription for drugs shall only be dispensed if the prescription is on one of those
forms, or, in the case of an emergency prescription given under the conditions specified in rule
7, if the person dispensing the prescription is acquainted with the signature of the medical
practitioner, dentist or veterinary surgeon by who the prescription purports to be given, or is
acquainted with the person for whose use the prescription is given and has no reason to
suppose that the prescription is not genuine;
(b) if an official form is not laid down, a prescription for drugs shall only be dispensed if
either—
(i) the person dispensing the prescription is acquainted with the signature of the person by
whom it purports to have been given, and has no reason to suppose that it is not genuine; or
(ii) the person dispensing the prescription has taken reasonably sufficient steps to satisfy
himself that it is genuine;
(c) if the prescription so directs, drugs may be supplied on more than one but not exceeding
Rev. 1983]
Dangerous Drugs
Cap. 245
13
three occasions, as directed in the prescription, at intervals to be specified in the prescription,
but drugs shall not otherwise be supplied more than once on the same prescription;
(d) the person dispensing a prescription shall mark thereon the date on which it is dispensed,
and shall retain it and keep it on the premises where it is dispensed so that it may be available
for inspection.
Conditions of possession.
9. No person shall be in possession of or attempt to obtain possession of a drug unless-,—
(a) he is licensed to import or export the drug; or
(b) he ii licensed or otherwise authorized to manufacture or supply the drug; or
(c) he is otherwise licensed by the Director of Medical Services or authorized by this Part or by
an authority granted by the Director of Medical Services to be in possession of the drug; or
(d) he proves that the drug was supplied for his use by a medical practitioner or a veterinary
surgeon or on and in accordance with a prescription:
Provided that this provision shall not apply in the case of a drug supplied to a person for his
use by a medical practitioner or in accordance with a prescription if that person was at the
time of the supply in course of receiving treatment from another medical practitioner in
respect of addiction to any of the drugs or otherwise, and of being supplied with any of the
drugs by or on a prescription given by that last-mentioned practitioner, and did not disclose
that fact to the first mentioned practitioner before the drug was supplied to him.
Marking of packages or bottles.
10. (1) No person shall supply a drug unless the package or bottle containing it is plainly
marked with the nature and amount of the drug contained therein.
(2) No person shall supply a preparation, admixture, extract or other article containing a drug
unless the package or bottle is plainly marked—
(a) in the case of a powder, solution or ointment, with the total amount thereof in the package
or bottle and the percentage of the drug in the powder, solution or ointment;
(b) in the case of tablets or other articles, with the amount of the drug in each article and thenumber of articles in the package or bottle.
(3) This rule shall not apply to a preparation dispensed by a medical practitioner or on the
proscription of a medical practitioner.
Registers to be kept my persons supplying.
11. (1) A person who is authorized to manufacture, supply, purchase, procure or otherwise
obtain, possess, administer or dispense drugs shall comply with the following provisions—
(a) be shall enter or cause to be entered in a register kept for the sole purpose all supplies of
drugs purchased or otherwise obtained by him and all dealings in drugs effected by him
(including sales or supplies to persons outside Kenya) in the form and containing the
particulars prescribed in the First Schedule;
(b) he shall make the entry with respect to drugs purchased or otherwise obtained by him on
the day on which the drug is received, and with respect to a sale or supply by him of the drug
on the day on which the transaction is effected; or, where that is not reasonably practicable,
on the day after the day on which the drug is received or the transaction is effected;
14
Cap. 245
Dangerous Drugs
[Rev. 1983
(c) where he carries on business at more than one set of premises, he shall keep a separate
register or registers in respect of each set of premises;
(d) he shall keep the register or registers in some part of the premises to which it relates, so
that it or they shall at all times be available for inspection in accordance with the
provisions of the Act;
(e) he shall not cancel obliterate or alter an entry in the register or make therein an entry
which is untrue in any particular but any mistake in an entry may be corrected by a marginal
note or footnote giving the correct particulars and dated:
and (f) he shall furnish to the Director of Medical Services, or to a person authorized by an order of
the Director of Medical Services for the purpose, such particulars as the Director of Medical
Services or such person may require in regard to purchases by him of drugs, stocks held by
him of drugs and transactions effected by him in drugs.
(2 (Deleted by L.N. 151/1968.)
(3) With the approval of the Director of Medical Services, separate registers may be kept for
separate departments of a business.
Alternatives to keeping of register.
12. (1) A medical practitioner who records in a daybook particulars of drugs administered,
dispensed or supplied by him or by another person under his direct supervision or in his
presence to a patient, together with the name and address of the patient and the date of the
administration, dispensation or supply, may, in lieu of keeping the register required by rule
11, enter separately for each drug, in a separate book to be kept for the purpose, a proper
reference to each entry in the day book which relates to the supply of a drug.
(2) A person lawfully keeping open shop for the retailing of poisons may, in lieu of keeping the
register required by this Part, enter in a separate book to be kept for the purpose a proper
reference to each entry in the Sale of Poisons Book kept by him relating to supply of drugs.
Meaning of “proper reference”.
13. In rule 12, “a proper reference” means a reference which is entered in the separate book
under the same date as that on which the entry in the day book or in the Sale of Poisons Book
was made and is otherwise such as to enable that entry to be easily identified.
Inspection of registers.
14. All such books shall at all times be available for inspection in accordance with the
provisions of the Act.
Seller of poisons may manufacture, etc., in certain cases.
Cap 244.
15. (1) A person lawfully keeping open shop for the retailing of poisons in accordance with the
Pharmacy and Poisons Act may—
(a) manufacture at the shop in the ordinary course of his retail business any preparation,
admixture or extract of drugs;
(b) carry on at the shop the business of retailing, dispensing or compounding drugs, but
subject to the provisions of this Part.
(2) Every drug in the actual custody of a person authorized by virtue of this rule shall be kept
in a locked receptacle which can be opened only by him or by some assistant of his being an
authorized seller of poisons within the meaning of section 24 of the Pharmacy and Poisons Act.
Rev. 1983]
Dangerous Drugs
Cap. 245
15
(3) In the event of any such person being convicted of an offence under this Part or of an
offence under any law relating to the customs, the Director of Medical Services may by notice
in the Gazette withdraw the authorization in paragraph (1) if, in the opinion of the Director of
Medical Services, that person cannot properly be allowed to carry on the business of
manufacturing, selling or distributing, as the case may be, drugs.
Medical practitioner, etc., may possess and supply drugs in certain cases.
16. A medical practitioner, dentist or veterinary surgeon, or a person employed or engaged in
dispensing medicines at. a public hospital or other public institution, or a person in charge of a
laboratory for the purposes of research or instruction attached to a public hospital, or other
institution approved by the Director of Medical Services for the purpose, may, so far as is
necessary for the practice of his profession or employment in that capacity, be in possession
of and supply drugs; but a dentist shall not supply otherwise than by the personal
administration thereof by him to persons receiving treatment from him.
Withdrawal of authority.
17. (1) if a person authorized by this Part or by an authority granted by the Director of Medical
Services to manufacture, supply or possess drugs is convicted of an offence under the Act or
these Rules or under any law relating to the customs as applied by the Act or these Rules, the
Director of Medical Services may, if he is of the opinion that that person ought not to be
allowed to manufacture, supply or possess drugs, by notice in the Gazette, withdraw the
authority of that person: but nothing in this rule shall prejudice any power otherwise vested in
the Director of Medical Services of withdrawing an authority given by him.
(2) Where the person whose authority is withdrawn under paragraph (1) is a medical
practitioner, dentist or veterinary surgeon, the Director of Medical Services may, by notice in
the Gazette, direct that that person shall not give prescriptions for the purposes of these
Rules.
(3) If the Director of Medical Services has reason to suspect that a medical practitioner or
dentist is supplying or prescribing drugs to or for himself or another person otherwise than is
properly required for the purpose of medical or dental treatment of himself or that other
person the Director of Medical Services may refer the matter to the Board constituted under
section 4 of the Medical Practitioners and Dentists Act (Cap. 253), and, if the Board so
recommends, the Director of Medical Services may, by notice in the Gazette, withdraw the
authority of the medical practitioner or dentist to supply, procure or possess drugs and give
the direction with respect to him as may be given under paragraph (2).
Delivery to messengers.
18. (1) No person shall deliver drugs to a person not licensed or otherwise authorized to be in
possession of drugs who purports to be sent by or on behalf of a person so 1icensed or
authorized, unless the first-mentioned person produces an authority in writing, signed by the
person so licensed or authorized, to receive the drug on his behalf, and unless the person
supplying the drug is satisfied that the authority is genuine.
(2) A person to whom a drug is lawfully delivered in the circumstances, mentioned in
paragraph (1) shall be deemed to be a person authorized to be in possession thereof, but for
such period only as in the circumstances of the case is reasonably sufficient to enable the
delivery to the recipient to be effected.
(3) This rule shall not apply to medicines dispensed in accordance with the provisions of this
Part.
When drugs in possession of person.
19. Drugs in the order or disposition of a person shall be deemed to be in his possession.
Power to exempt hospitals
20. The Minister may exempt from the operation of this Part any hospital or other public
16
Cap. 245
Dangerous Drugs
[Rev. 1983
institution, subject to the observance of such conditions as he may prescribe.
Exemption of certain preparations.
21. (1) This Part shall not apply to drugs when denatured in a manner approved by the
Minister nor to preparations named in the Third Schedule.
(2) The Minister may, by order, add or remove a preparation to or from the Third Schedule.
Preservation of records.
22. Prescriptions, records, registers or other documents required to be retained or kept in
pursuance of this Part or an order made thereunder shall be preserved for not less than two
years from the date of the prescription or document or the last entry in the record or register,
as the case may be.
PART III—CONTROL OF EXTERNAL TRADE
Interpretation of Part.
23. In this Part, except where the contest otherwise requires—
“conveyance” includes a ship, motor vehicle, aircraft, train and any other means of transport
by which goods may be imported-or exported;
“diversion certificate” means a certificate issued by the competent authority of a country
through which a dangerous drug passes in transit, authorizing the diversion of the drug to a
country other than that specified as the country of ultimate destination in the export
authorization, and containing all the particulars required to be included in an export
authorization, together with the name of the country from which the consignment was
originally exported; “export”, in relation to Kenya, means export otherwise than in transit;
“export authorization” means an authorization issued by a competent authority in a country
from which a dangerous drug is exported, containing full particulars of the drug and the
quantity authorized to be exported, together with the names and addresses of the exporter
and the person to whom it is to be sent, and stating the country to which, and the period
within which, it is to be exported;
“import”, in relation to Kenya, means export otherwise than in transit;
“import authorization” means a licence, issued by a competent authority, authorizing the
importation of a specific quantity of a dangerous drug and containing full particulars of the
drug, together with the name and address of the person authorized to import the drug and the
name and address of the person from whom the drug is to be obtained, and specifying the
period within which he importation must be effected; “import certificate” means a certificate substantially in Form A in the Second Schedule, issued
by a competent authority in a country into which it is intended to import dangerous drugs;
“in transit” means taken or sent from one country and imported (whether or not landed or
transhipped in Kenya) for the sole purpose of being carried to another country by either the
same or another conveyance.
Export of dangerous drugs.
24. (1) Upon the production of an import certificate issued, by the competent authority in any
country, the Director of Medical Services may issue an export authorization in Form B in the
Second Schedule, in respect of a drug referred to in the import certificate, to a person who is
named as the exporter in the certificate and is, under the Act, otherwise lawfully entitled to
export the drug.
Rev. 1983]
Dangerous Drugs
Cap. 245
17
(2) The export authorization shall be prepared in triplicate, two copies of which shall be issued
to the exporter, who shall send one copy with the drug to which it when the drug is exported;
and the Director of Medical Services shall send the third copy direct to the appropriate
authority of the country of ultimate destination.
(3) Where the intended exportation is to a country which is not a party to the Geneva
Convention (No. 1), it shall not be necessary to produce an import certificate.
(4) In all cases it shall be in the absolute discretion of the Director of Medical Services to issue
or refuse an export authorization.
(5) No dangerous drug shall be exported unless the consignor is in possession of a valid and
subsisting export authorization relating to the drug granted under these Rules.
(6) At the time of exportation of a dangerous drug, the exporter shall produce to the
Commissioner of Customs and Excise the dangerous drug, the expert authorization relating
(hereto and such other evidence as the Commissioner of Customs and Excise may require to
satisfy him that the drug is being lawfully exported to the place and person named in the
authorization which refers t it.
(7) No person shall export or take any stops preparatory to exporting a dangerous drug
except in pursuance of and in accordance with these Rules.
Import of dangerous drugs.
25. (1) An import authorization in Form C in the Second Schedule permitting the importation
of a dangerous drug specified therein may be granted by the Director of Medical Services
subject to such conditions as he deems lit to a person who may lawfully import the drug.
(2) Every import authorization shall be issued in duplicate, of which one copy shall be
forwarded by the intending importer to the person from whom, the drug is to be obtained.
(3) No dangerous drug shall be imported unless the person to whom the drug is consigned is
in possession of a valid and subsisting import authorization granted in pursuance of this rule.
(4) Every dangerous drug imported from a country which is party to the Geneva Convention
(No. 1) shall be accompanied by a valid and subsisting export authorization or diversion
certificate.
(5) No person shall import or take any steps preparatory, to importing a dangerous drug
except in pursuance of and in accordance with these Rules.
Dangerous drugs in transit.
26. (1) No person shall bring a dangerous drug into Kenya in Dangerous transit unless—
(a) the drug is in course of transit from a country from which it may lawfully be exported, to
another country into which the drug may lawfully be imported; and
(b) except where the drug comes from a country not a party to the Geneva Convention
(No.1), it is accompanied by a valid and subsisting export authorization or diversion
certificate, as the case may be.
(2) Where a dangerous drug in transit is accompanied by an export authorization or diversion
certificate and a customs officer has reasonable grounds for believing that the authorization or
certificate is false, or that it has been obtained by fraud or wilful misrepresentation of a
material particular, the customs officer may seize and detain the drug to which that
authorization or certificate relates; but upon being satisfied that the authorization or certificate
is valid or has not been obtained by fraud or misrepresentation, the customs officer shall
release the drug.
18
Cap. 245
Dangerous Drugs
[Rev. 1983
(3) Where the dangerous drug in transit is not accompanied by an export authorization or
diversion certificate by reason of the fact that the drug comes from a country not a party to
the Geneva Convention (No. 1), and a customs officer, administrative officer or police officer
has reasonable grounds for believing that the drug is being conveyed in an unlawful manner or
for an unlawful purpose or is in course of transit for the purpose of being imported into
another country in contravention of the laws of that country, the customs officer,
administrative officer or police officer may seize and detain the drug.
(4) Where a dangerous drug brought into Kenya in transit is landed, or transhipped in Kenya it
shall remain under the control of the Commissioner of Customs and Excise, and shall be
moved only under and in accordance with a removal licence granted under rule 27.
(5) Nothing in this rule shall apply to a dangerous drug in transit by post or in transit by air if
the aircraft passes over Kenya without landing, or to such quantities of dangerous drugs as
may, bona fide, reasonably form part of the medical stores of a ship or aircraft. Removal licence.
21. (1) No person shall—
(a) remove a dangerous drug from the conveyance by which it is brought into Kenya in
transit; or
(b) in any way move any such drug in Kenya at any time after removal from the conveyance
except under and in accordance with a licence in Form U in the Second Schedule (in these
Rules referred to as a removal licence) issued by the Commissioner of Customs and Excise;
and in all cases it shall be in the absolute discretion of the Commissioner of Customs and
Excise to issue or refuse a removal licence.
(2) No removal liceuce for the transfer of a dangerous drug to a conveyance for removal out of
Kenya shall be issued unless and until a valid and subsisting export authorization or diversion
certificate relating to it is produced to the Commissioner of Customs and Excise, but where the
drug has come from a country not a party to the Geneva Convention (No. 1) this paragraph
shall not apply.
(3) This rule shall not apply to dangerous drugs in transit by post.
Drugs not to be tampered with.
28. No person shall cause a dangerous drug in transit to be subjected to a process which
would alter its nature, or wilfully open or break a package containing a dangerous drug in
transit except upon the instructions of the Commissioner of Customs and Excise and in such
manner as he may direct
29. (1) No person shall, except under the authority of a diversion certificate in Form B in the
Second Schedule, cause or procure a dangerous drug brought into Kenya in transit to be
diverted to a destination other than that to which it was originally consigned; and in the case
of a drug in transit accompanied by an export authorization or a diversion certificate issued by
a competent authority of some other country, the country to which the drug was originally
consigned shall be deemed to be the country slated in the export authorization or diversion
certificate to be the country of destination.
(2) The Director of Medical Services may issue a diversion certificate of a dangerous drug in
transit upon production to him of a valid and subsisting import certificate issued by a
competent authority in the country to which it is proposed to divert the drug, or if that
country is not a party to the Geneva Convention (No. 1) upon such evidence as may satisfy
him that the drug is to be sent in a lawful manner and for a proper purpose.
(3) A diversion certificate shall be issued in duplicate; one copy thereof shall accompany the
drug when it is exported, and another copy shall be dispatched by the Director of Medical
Services direct to the proper authority in the country to which the consignment has been
Rev. 1983]
Dangerous Drugs
Cap. 245
19
diverted.
(4) Upon the issue of a diversion certificate, the export authorization or diversion certificate (if
any) accompanying the drug on its arrival in Kenya shall be detained by the customs officer
and returned to the authority issuing the authorization or diversion certificate, together with a
notification of the name of the country to which the drug has been diverted.
Periodical returns.
30. (1) A person being in possession of or producing or manufacturing a drug in Kenya shall
furnish to the Director of Medical Services, at such intervals as he may specify, such
particulars and returns as he may require in regard thereto.
(2) A person importing a drug shall furnish in the month of January in every year to the
Director of Medical Services an estimate of the amount of any such drugs to be imported by
him during that year.
Drugs to be imported or exported only through appointed ports. Cap. 472
31. The importation or exportation of any drug to which these Rules apply shall be permissible
only through the ports appointed imported or under section 9 of the Customs and Excise Act.
Name of
substance
purchased or
otherwise
obtained
Date on
which supply
received
Name of
person, body
or firm from
whom
obtained
Address of
person, body
or firm from
whom
obtained
Amount
obtained
Form in
which
obtained
(b) REGISTER OF DRUGS TO WHICH PART V OF THE DANGEROUS DRUGS ACT APPLIES –
SOLD OR SUPPLIED
Name of
substance
sold or
supplied
Date on
which
transaction
was
effected
Name of
person,
body or
firm to
whom
sold or
supplied
Address
of
person,
body or
firm to
whom
sold or
supplied
Authority
of person,
body or
firm to be
in
possession
of the
substance
Amount
sold or
supplied
Form in
which
sold or
supplied
SECOND SCHEDULE
Form A (r.23)
Import Certificate issued by
the Government of Kenya.
Serial No. ………………
File No. ………………….
INTERNATIONAL OPIUM CONVENTIONS
THE DANGEROUS DRUGS ACT
IMPORT AUTHORIZATION
When sale
is on a
prescription,
specify the
ingredients
or the
prescription
20
Cap. 245
Dangerous Drugs
[Rev. 1983
I, being the person charged with the administration of the law relating to dangerous drugs to
which the International Opium Conventions apply, hereby certify that I have approved the
importation by*
*Here insert
name address
and business of
importer.
†Here insert
exact description
and amount of
drugs to be
imported.
‡Here insert
name and
address of firm
in exporting
country from
which the drug is
to be obtained.
subject to the conditions that—
(i) the consignment shall be imported before the and
(ii) the consignment shall be imported by
and that I am satisfied that the consignment proposed to be imported
is required—
(1) for legitimate purposes;
§ Strike out
words not
applicable (2) § solely for medicinal or scientific purposes.
………………………………………………………………………
Signature and stamp of the authority which
has issued the import authorization
Date ……………………………
Form B (r. 24)
File No ……………………….
Applicant's
Reference No ………………..
Serial No……………………….
Rev. 1983]
Dangerous Drugs
Cap. 245
21
THE DANGEROUS DRUGS ACT
EXPORT AUTHORIZATION
In pursuance of the Dangerous Drugs Act, the Director of Medical Services hereby authorizes
(hereinafter called the exporter)
*Strike out
words not
applicable
to export from
(1) *the port of by S.S.
(2) *Kenya by parcel post in
parcels from the
to
Post Office
in
in virtue of Import Certificate No.
issued by
dated
the following drugs, namely:—
This authorization is issued subject to the following conditions:1. This authorization is not a licence to obtain or be in possession of the drugs named herein.
2. This authorization is available only for drugs of the exact quantity, kind and form specified
above.
3. This authorization does not relieve the exporter from compliance with ant customs
regulations in force for the time being relating to the exportation of goods from Kenya nor
from any provision of the Kenya Posts and Telecommunications Corporation Act, or of any
regulations made thereunder, nor from any rules or regulations respecting the transmission of
articles by post which may for the time being be in force, whether within Kenya or elsewhere.
4. If the drugs are authorized, to be exported by ship the duplicate copy, which is attached,
shall accompany the consignment to the place of destination, and for this purpose the
exporter shall cause it to be delivered to the master of the vessel by which the consignment is
dispatched. (See footnote (3).)
5. If the drugs are authorized to be exported by post the attached duplicate copy shall be
placed inside the outer wrapper of the parcel containing the drugs. If the drugs are contained
in more than one parcel, the duplicate copy shall be placed inside the outer wrapper of one of
them; the parcels shall be consecutively numbered on the outer wrapper, and on each parcel
there shall be legibly stated the number of the parcel in which the duplicate copy is to be
found. (See footnote (2).)
6. The exporter, if so required by the Commissioner of Customs and Excise, shall produce to
him, within such time as he may allow, proof to his satisfaction that the drugs were duly
delivered at the destination named in this authorization, and in the event of noncompliance
with this condition the authorization shall be deemed void and of no effect.
7. The exporter shall furnish to the Director of Medical Services such returns of the goods
exported by him in pursuance of this authorization as may from time to time be required.
22
Cap. 245
Dangerous Drugs
[Rev. 1983
8. This authorization is valid only for the exporter named above, and may be revoked at any
time by the Director of Medical Services. It shall be produced for inspection when required by
any duly authorized person.
9. This authorization, unless sooner revoked, shall continue in force for three calendar months
from the date hereof. It must be produced, at the time of export, to an officer of—
*the Customs and Excise Department,
*the Kenya Posts and Telecommunications Corporation,
who will retain it.
If not used, it shall be surrendered to the Director of Medical Services within seven days of the
date of its expiry
*Strike out
words not
Applicable.
Date
……………………………………………………………
Signature and stamp of Director
of Medical Services
Notes.—(1) it any alteration is desired in this authorization, it must be returned with a request for
amendment and a statement of the reasons therefor. No unauthorized alteration is permissible.
(2) In the case of drugs exported by post, failure to comply with this condition may lead to delay or
confiscation of the parcels in the country of destination.
(3) In the case of drugs exported by skip, this document is required in pursuance of the International
Opium Convention, 1925, Article 15, to be produced to the competent authorities of any country through
which the consignment passes, whether it is transhipped or not. Failure to comply with the condition may
lead to delay or confiscation of the consignment.
Form C
(r. 25)
INTERNATIONAL OPIUM CONVENTION
THE DANGEROUS DRUGS ACT
IMPORT AUTHORIZATION AND CERTIFICATE OF OFFICIAL APPROVAL OF IMPORT
I, being the person charged with the administration of the law relating to the dangerous drugs
to which the International Opium Conventions apply, hereby certify that I have authorized*
* Here insert
name and full
postal address
of importer.
(hereinafter called the importer) to import the drugs specified in the Schedule hereto, which I
am satisfied are required:—
† Strike out
words not
applicable.
(1) † for legitimate purposes [in the case of raw opium or the coca leaf]
Rev. 1983]
Dangerous Drugs
Cap. 245
23
(2) † solely for medicinal or scientific purposes [in the case of Indian hemp or drugs to which
Chapter III of the International Opium Convention, 1925, applies]
†Here insert
name and
full postal
address of
exporter.
from‡
This authorization is issued subject to the following conditions:—
1. The drugs shall be imported before [date].
2. This authorization is not a licence to be in possession of or to supply the drug imported.
3. This authorization does not relieve the importer from compliance with any customs
regulations in force for the time being relating to the importation of goods into or
transhipment of goods in Kenya or any postal regulations for the time being in force in Kenya.
4. This authorization is valid only for the importer, and may be revoked at any time and in
that event shall be immediately surrendered. It shall be produced for inspection when required
by any duly authorized person.
5. This authorization unless sooner revoked shall be surrendered to the Customs Officer at the
time of importation, or, if the importation is not effected before the date specified in condition
No. 1, shall immediately after that date be surrendered to the Director of Medical Services.
6. The copy of the export authorization, if any, which accompanies the consignment shall be
forwarded to the Director of Medical Services immediately the importation of the consignment
has been effected.
Date
………………………………………………………….
Signature and stamp of the
issuing authorial
SCHEDULE specifying the drugs and quantities thereof to be imported.
One copy of this authorization is to be retained by the importer, and is not to leave his
possession until it is surrendered to the Director of Medical Services, or to the Customs
Officer, who will complete the certificate on the back and return it to the Director of Medical
Services.
The duplicate copy is solely for production to the government of the country from which the
drug is proposed to be obtained.
ENDORSEMENT BY CUSTOMS OFFICER AT THE TIME OF IMPORTATION
I hereby certify that the person named overleaf has today imported the consignment thereon
specified ‡ ex‼
under Customs Entry No. dated
¶by registered parcel post or insured box post (Parcel No.
dated
24
Cap. 245
Dangerous Drugs
[Rev. 1983
§See note below.
‼Insert name of
ship.
¶Strike out all
words
inapplicable
Port Stamp
…………………………………………………….
Signature of Customs Officer
Rank ………………………………………………..
Port ………………………………………………….
Date ………………………………
§ If the whole of the drugs for which this authorization has been granted is not imported, the
Custom Officer should suitably amend the certificate above, and insert below the actua
amount or items-imported.
Amount
Description of items
This authorization, when completed, must be returned by the Customs Officer to the Director of Medical
Services.
Form D
THE DANGEROUS DRUGS ACT
(r. 27)
LICENCE FOR THE REMOVAL OF DANGEROUS DRUGS TN TRANSIT ……………………………… is
hereby authorized to move the dangerous drugs described hereunder from ………………
To …………………………………
Nature and quantity of dangerous drugs ………………………..
Particulars of export authorization (or diversion certificate) if any, relating thereto ……….
Name of ship on which the drugs were brought into Kenya ………………………………………..
…………………………………………………………………………………………………………………………………………..
Date of arrival ………………………………………………………………………………………………………………..
Number of packages ……………………………………………………………………………………………………..
Marks and numbers on packages ………………………………………………………………………………..
This licence is issued subject to the following conditions:—
1. This licence is valid only for the removal of the drugs specified above.
2. The removal of the drugs shall take place between .... a.m./p.m. and .... a.m./p.m. on the
19. ..
Rev. 1983]
Dangerous Drugs
Cap. 245
25
3. If the removal of the drugs does not take place within the hours and on the day specified,
this licence must be returned to the Commissioner of Customs and Excise forthwith; and in
any case shall be surrendered when the removal has taken place.
4. The drugs must not be moved unless an officer of the Customs and Excise Department is
present
5. This licence does not authorise the person named above to be in possession of the drugs
otherwise than for the purpose of removing them in accordance with this licence.
6. The packages containing the drugs are not to be opened or broken in the course of the
removal.
7. This licence shall be produced at any time when required by a duly authorized person.
Date ……………………………….
……………………………………………
Signature and stamp of the
issuing authority
Form E (r. 29)
INTERNATIONAL OPIUM CONVENTIONS
THE DANGEROUS DRUGS ACT
DIVERSION CERTIFICATE
I, being the person charged with the administration of the law relating to the dangerous drugs
to which the International Opium Conventions apply, hereby certify that I have authorized the
diversion of the consignment of drugs, of which particulars are given below, to the destination
stated below.
Description and quantities of drugs …………………………………………………………….
Name of vessel on which the consignment was brought to Kenya ………………………….
Number and date of export authorization and authority by whom issued ……………
Name and address of original consignee named in the export authorization …………..
Name and address of consignee to whom consignment is authorized to be diverted
…………………………………
Number and date of import certificate (and authority by whom issued) by virtue of which this
diversion is authorized ……………………………………..
Name of vessel on which the consignment is authorized to be carried from [name of port of
Kenya] ………………………………………………………….
Period within which the consignment is to be carried from
Kenya ………………………………………………………………………………………….
This certificate is issued subject to the following conditions:—
1. The duplicate copy of this certificate shall accompany the consignment to the place of
destination, and for this purpose shall be delivered to the master of the vessel by which the
consignment is dispatched.
2. This certificate does not relieve any person who may be concerned with the carriage of the
consignment of drugs specified above from compliance with any Customs regulations in force
for the time being relating to the exportation of goods from Kenya.
3. This certificate is valid only for the consignment and for the period specified above, and
may be revoked at any time.
4. If the consignment of drugs is not carried from Kenya within the period specified above this
certificate shall be surrendered to the Director of Medical Services.
5. This certificate shall be produced at any time when required by a duly authorized -person.
26
Cap. 245
Dangerous Drugs
[Rev. 1983
…………………………………………………
Signature and stamp of the
issuing authority
Date ……………………………..
Notes.—(1) If any alteration is desired in this authorization, it must be returned with a request for
amendment and a statement of the reasons therefor. No unauthorized , alteration is permissible.
(2) This document is required, in pursuance of the International Opium Convention, 1925, Article 15, to be
produced to the competent authorities of any country through which the consignment passes, whether it is
t, unshipped or not. Failure to comply with the condition may lead to delay or confiscation of the
consignment.
THIRD SCHEDULE
(r. 21)
(a) MORPHINE PREPARATIONS
1.Cereoli idioformi et
morphinae
2.Emplastrum opii
3.Emplastrum opii
4.Emplastrum opii
5. Emplastrum opii
6. Emplastrum opii (see
formula under 5)
7. Linimentum opii
8.Linimentum opii
(seeformula under 7)
9. Linimetum opii
ammoniatum
10. Linimentum opii
ammoniatum
(seeformula under 9)
Idioform
Morphine hydrochloride
Oil of theobroma, sufficient to fill
a 1-gramme mould
Elemi
Terebinthina
Cera flava
Olibanum pulvis
Benzoes pulvis
Opii pulvis
Balsami peruviani
Extract of opium
Refined elemi
Diachylon plaster with gum
Elemi
Terebinthinoe communis
Cerae flavae
Olibani pulveratae
Benzoes pulveratae
Opii pulverati
Balsami peruviani
Opium, in very fine powder
Resin plaster
Mixed with other plasters
contained the British
Pharmacopoeia or British
Pharmaceutical Codex.
Tincture of opium
Liniment of soap
Mixed with any other liniment of
the British Pharmacopoeia or of
the British Pharmaceutical
Codex.
Ammoniated liniment of
camphor
Tincture of opium
Liniment of belladonna
Strong solution of ammonia
Liniment of soap to
Mixed with any other British
Pharmacopoeia or British
Pharmaceutical Codex liniment.
In 1 bougie
0.320 gramme
0.016 gramme
20 grammes
30 ,,
15 ,,
18 ,,
10 ,,
5 ,,
2 ,,
25 ,,
25 ,,
50 ,,
8 ,,
15 ,,
5 ,,
8 ,,
4 ,,
2 ,,
1 grammes
10 grammes
90 ,,
500 millilitres
500 ,,
30
30
5
5
100
Rev. 1983]
11. Caustic "Nerve
Pastes"
12. Diarrhoea pills
13. Pilulae digitalis et
Opii compositae
14. Pilulae hydrargyri
cum Opio
15. Pilulae hydrargyri
cum Creta et Opii
16. Pilulae ipecacuanha
cum Scilla
17. Pilulae hydrargyri
bichlorati cum Opii
extracto
18. Pilulae hydrargyri
iodati cum Opii pulvere
19. Pilula plumbi cum
Opio
20. Pilulae Terebinthinae
compositae
21. Pulvis ipecacuanhae
compositus Syn.: Pulvis
ipecacuanhae
et Opii (Dovers powder)
22. Mixtures of Dovers
powder (seeformula
under 21)
23. Pulvis kino
compositus
Dangerous Drugs
Preparations containing, in
addition to morphine salts, or
morphine and cocaine salts, and
made up with the requisite
proportion of creosote or phenol
to produce the consistency of a
paste.
Camphor
Lead acetate
Bismuth subnitrate
Tannic acid
Opium powder
Digitalis leaves, in powder
Opium in powder
Ipecacuanha root, in powder
Quinine sulphate
Syrup of glucose, a sufficient
quantity to make 12 pills.
Mercury pill
Opium, in powder
To make 12 pills.
Mercury, with chalk
Compound powder of
ipecacuanha *
Milk, sugar, a sufficient quantity
Syrup of glucose, a sufficient
quantity.
To make 12 pills
Compound powder of
ipecacuanha*
Squill, in powder
Ammoniacum, in powder
Syrup of glucose, a sufficient
quantity.
Bichloride of mercury triturated
Extract of opium
Extract of couch-grass
Liquorice root in powder,
quantity sufficient for 10 pills.
Hydrargyrum iodatum freshly
prepared
Opium powder
Powdered liquorice
White honey, quantity sufficient
for ten pills.
Lead acetate, in powder
Opium, in powder
Syrup of glucose (or a sufficient
quantity).
Opium
Chinini sulfas
Styrax liquidus
Terebinthina laricina
Magnesii subcarbonas, a
sufficient quantity to make 100
pills.
Ipecacuanha root, in powder
Opium in powder
Potassium sulpahate in powder
With mercury and chalk, aspirin,
phenacetin, quinine and its
salts, and sodium bicarbonate.
Kino, in powder
Opium, in powder
Cap. 245
0.0648 gramme
0.013 ,,
0.162 ,,
0.068 ,,
0.026 ,,
0.31 gramme
0.19 ,,
0.13 ,,
0.78 ,,
3.89 grammes
0.19 gramme
0.78 gramme
0.78 gramme
30 grammes
10 ,,
10 ,,
10
20
20
20
centigrammes
,,
,,
,,
50 ,,
20 ,,
30 ,,
80 grammes
12 ,,
8 ,,
0.5 gramme
2 gramme
2 ,,
8 ,,
10 ,,
10 ,,
80 ,,
75 grammes
5 ,,
27
28
Cap. 245
24.Suppositoria plumbi
composita. Syn.: Suppositoria plumbi cum
Opio
25. Coryza Tablets No.2
26. Diarrhoea Tablets
No.2
27. Dysentry Tablets
28. Tabella hydrargyri
cum Opio
29.Tabella hydrargyri
cum Opio
30.Tabella hydrargyri
cum Opio
31.Unguentum gallae
compositum
32. Unguentum gallae
compositum (seeformula
under 31)
33. Unguentum gallae
cum
Opio
34.Unguentum gallae
cum Opio (seeformula
under 33)
35.Yatren-105
(Iodoxyquinoline-sulphonic acid)
1.Bernatzik's Injections
2. Stila's Injections
Dangerous Drugs
Cinnamon bark, in powder
Lead acetate, in powder
Opium, in powder
Oil of theobroma, a sufficient
quantity for
12 suppositories, each weighing
about
Powdered opium
Quinine sulph.
Ammon. chlor
Camhpor
Ext. Belladonna leaves
Ext. aconite root
Powdered opium
Camphor
Powdered ipecacuanha
Lead acetate
Powdered opium
Powdered ipecacuanha
Powdered calomel
Lead acetate
Bismuth betanaphthol
Mercurous chloride powder
Antimony oxide powder
Ipecacuanha-root powder
Powdered opium
Milk sugar
Gelatine solution, a sufficient
quantity to make 1 tablet.
Sugar of lead
Powdered opium
Gelatine solution, a sufficient
quantity to make 1 tablet.
Lead acetate, in powder
Opium, in powdered
Refined sugar, in powder
Ethereal solution of theobroma
Alcohol
Galls in very fine powder
Extracts of opium
Distilled water
Wool fat
Soft parrafin, yellow
Mixed with other ointments and
plasters contained in the british
Pharmacopoeai or British
Pharmaceutical Codex.
Gall ointment
Opium in powder
[Rev. 1983
20 ,,
2.4 ,,
0.8 gramme
1 gramme
0.0043 gramme
0.022 ,,
0.022 ,,
0.022 ,,
0.0043 ,,
0.0043 ,,
0.016 ,,
0.016 ,,
0.008 ,,
0.011 ,,
0.013 ,,
0.0648 ,,
0.0324 ,,
0.0324 ,,
0.1944 ,,
0.065 ,,
0.065 ,,
0.065 ,,
0.065 ,,
0.065 ,,
0.195 ,,
0.065 ,,
19.44 grammes
3.24 ,,
6.48 ,,
3.60 mils.
0.90 mil
20
4
16
10
50
92.5 grammes
7.5 ,,
Mixed with other ointments and
plasters contained in the british
Pharmacopoeai or British
Pharmaceutical Codex.
With 5 per cent opium
admixture.
(b) COCAINE PREPARATIONS
(a) Hydrargyrum bicyanatum
Cocainum
(b) Hydrargyrum succinatum
Cocainum
(a) Hydrargyrum succinatum
Cocainum muriaticum
(b) Hydrargyrum succinatum
0.03
0.02
0.03
0.01
0.03
0.01
0.05
grammes
,,
,,
,,
,,
,,
,,
Rev. 1983]
3.Natrium biboracicum
compositum cum Cocaino
4.Caustic "Nerve Pastes"
5. Cocaine and Atropine
Tablets, with a content
of not more than 0.0003
gramme of atropine salts
to each tablet
1. Elixir camphorae
compositum
2. Elixir diamorphinae et
Terpini, with
Apomorphine
3. Linctus diamorphinae,
with Ipecacuanha
4. Linctus senegae
compositus
5. Linctus thymi
compitus
1. Cardiazol-Dicodide
Solution
Dangerous Drugs
Cocainum muriaticum
In tablets, compressed tablets,
lozenges, pastilles and the like,
difficult to break up, and
containing not more than 0.2
per cent of cocaine salts in
conjunction with not less than
20 per cent antipyrine, or some
similar analgesic, and not more
than 40 per cent of flavouring
matter. Maximum weight of
each tablet, etc., 1 gramme.
Preparations containing, in
addition to cocaine and
morphine salts, at least 25 per
cent of arsenoius acid, and
made up with the requisite
proportion of cresoate or phenol
to produce the consistency of a
paste.
Atropinum sulphuricum
Cocainum hydrochloricum
Mannite
Weight of one tablet
Cocaine content 8.3 per cent.
(c) HEROIN PREPARATIONS
Camphor
Oil of anise
Benzoic acid
Diamorphine hydrochloride
Liquid extract of ipecacuanha
Tincture of squill
Simple syrup to 20fl. ounces
Amomorphine hydrochloride
Diamorphine hydrochloride
Terpin hydrate
Alcohol
Glycerine
Syrup of wild cherry to 20 fl.
ounces
Liquid extract of ipecacuanha
Diamorphine hydrochloride
Tincture of hyoscyamus
Spirit of chloroform
Syrup of balsam of tolu
Syrup of wild cherry
Glycerine to 20 fl. Ounces
Liquid extract of senega
Liquid extract of squill
Tartarated antimony
Diamorphine hydrochloride
Glycerine
Simple syrup to 20 fl. Ounces
Diamorphine hydrochloride
Apomorphine hydrochloride
Distilled water
Liquid extract of thyme (I-I)
Solution of tolu
Glycerine to 20 fl. Ounces
(d) DICODIDE PREPARTIONS
Solutions containing not less
than 10 per cent of cardiazol
and not more than 0.5 per cent
of dicodide salts
Cap. 245
0.03 ,,
0.0003 gramme
0.0003 ,,
0.003 ,,
_____________
0.0036 gramme
4 grains
5 minims
6 grains
4
120 minims
1½ fl. Ounces
5 grains
4 grains
44 grains
10 fl. Ounces
5“
120 minims
4 grains
1½ fl. Ounce
1½
“
3
“
3
“
1 fl. Ounce
1 “
8 grains
4 “
2. fl. Ounces
4 grains
5 “
1 fl ounce
5 fl ounces
1¼ “
29
30
Cap. 245
Dangerous Drugs
1. Anti-Opium Tablets*
2. Tablets B.B Compound
(e) EUCODAL PREPARATIONS
Eucodal
Pulvis gentianae
Pulvis ipecacuanhae
Quinine sulphate
Caffeine
Sugar of milk
Mix up and make up 5-grain
tablets.
Berberis vulgaris powder
Nux vomica
Eucodal
Ipecacuanha
Rhubarb
Pulvis cinnamoni comositus
Aromatic chalk
[Rev. 1983
1 gramme
35 grammes
20 ,,
20 ,,
5 ,,
0.0324 gramme
0.013 ,,
0.0032 ,,
0.0648 ,,
0.013 ,,
0.0324 ,,
0.0032 ,,
*In exempting this preparation from the operation of the Geneva Convention, the Health
Committee expressed the wish it should not be offered to the public under the name of “antiopium”.
Order under section 14 (4)
Cap. 129 (1948), Sub Leg., G.N. 253/1951, G.N. 1274/1951, G.N. 549/1953, L.N. 478/1958.
THE DANGEROUS DRUGS (APPLICATION) ORDER
1. This Order may be cited as the Dangerous Drugs (Application) Order.
2. Part V of the Act shall apply to the following drugs in the same manner as it applies to the
drugs mentioned in section 14 (1) of the Act –
Dihydrodesoxymorphine (commonly known as desomorphine), its salts and any preparation,
admixture, extract or other substance containing any proportion of dihydrodesoxymorphine.
Pethidine (1 methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester), its salts and any
preparation, admixture, extract or other substance containing any proportion of pethidine.
Alphaprodine (a-4-Propionoxy-4-phenyl-l : 3-dimethyl-4-piperidine), its salts and any
preparation, admixture, extract or other substance containing any proportion of betaprodine.
Amidone (6-Dimethylamino-4 : 4-diphenylheptan-3-one); its salts and any preparation,
admixture, extract or other substance containing any proportion of amidone.
Betaprodine (B-4-Propionoxy-4-phenyl-l : 3-dimethyl-4-piperidine), its salts and any
preparation, admixture, extract or other substance containing any proportion of betaprodine.
Demerol (l-methyl-4-phenyl-piperidine-4-carboxylic acid ethylester), its salts, and any
preparation, admixture, extract or other substance containing any proportion of demerol.
Hydroxypethidine (Ethyl 4-m-hydroxyphenyl-l-methylpiperidine-4-carboxylate), its salts and
any preparation, admixture, extract or other substance containing any proportion of
hydroxypethidine.
Isoamidone (6-Dimethylamino-4 : 4-diphenyl-5-methylhexan-3-one). its salts and any
preparation, admixture, extract or other substance containing any proportion of isoamidone.
Ketobemidone (4-Propionyl-4-m-hydroxyphenyl-l-methyI-piperidine), its salts and any
preparation, admixture, extract or other substance containing any proportion of
ketobemidone.
Rev. 1983]
Dangerous Drugs
Cap. 245
31
Methadol (6-Dimethylamino-4 : 4-diphenylheptan-3-ol), its salts and any preparation,
admixture, extract or other substance containing any proportion of methadol.
Methadyl acetate (6-Dimethylamino-4 : 4-diphenyl-3-heptyl-acetate), its salts and any
preparation, admixture, extract or other substance containing any proportion of methadyl
acetate.
Metopon (Methyldihydromorphinone) : its salts and any preparation, admixture, extract or
other substance containing any proportion of methyldihydromorphinone.
Phenadoxone (6-Morpholino-4 : 4-diphenylheptan-3-one), its salts and any preparation,
admixture, extract or other substance containing any proportion of phenadoxone.
Dihydrocodeincj its salts and any preparation, admixture, extract or other substance
containing any proportion of dihydrocodeine.
Acetyldihydrocodeine, its salts and any preparation, admixture, extract or other substance
containing any proportion of acetyldihydro-'
codeine.
4-Propionoxy-4-phenyl-l-methyl-3-ethylpiperidine, its salts and any preparation, admixture,
extract or other substance containing any proportion of 4-propionoxy-4-phenyl-l-methyl-3ethylpiperidine.
3-Hydroxy-N-methylmorphinan. its salts and a".y preparation,
admixture, extract or other substance containing any proportion of
3-hydroxy-N-methylmorphinan.
3-methoxy-N-methylmorphinan (that is to say, dextromethorphan, levomethorphan and
racemethorphan), its salts and any preparation, admixture, extract or other substance
containing any proportion of 3-methoxy-N-methylmorphinan.
Alphameprodine, its salts and any preparation, admixture, extract or other substance
containing any proportion of alphameprodine.
Alphaprodine, its salts and any preparation, admixture, extract or other substance containing
any proportion of alphaprodine.
Betameprodine, its salts and any preparation, admixture, extract or other substance
containing any proportion of betameprodine.
Diethylthiambutene, its salts and any preparation, admixture, extract or other substance
containing any proportion of diethylthiambutene.
1 : 3-Dimethyl-4-phenyl-4-propionyloxyhexamethyleneimine, its salts and any preparation,
admixture, extract or other substance containing any proportion of 1 : 3-dimethyl-4-phenyl-4propionyloxy hexamethyleneimine.
Dimethylthiambutene, its salts and any preparation, admixture, extract or other substance
containing any proportion of dimethylthiambutene.
Dioxaphetyl butyrate (4-morpholino-2:2-diphenyl ethyl butyrate), its salts and any
preparation, admixture, extract or other substance containing any proportion of dioxaphetyl
butyrate (4-morpholino 2 : 2-diphenyl ethyl butyrate).
Dipipanone, its salts and any preparation, admixture, extract or other substance containing
any proportion of dipipanone.
Ethylmethylthiambutene, its salts and any preparation, admixture, extract or other substance
containing any proportion of ethylmethylthiambutene.
32
Cap. 245
Dangerous Drugs
[Rev. 1983
Levorphanol, its salts and any preparation, admixture, extract or other substance containing
any proportion of levorphanol.
Methyldesomorphine (6-methyl-^6-desoxymorphine), its salts and any preparation, admixture,
extract or other substance containing any proportion of methyldesomorphine (6-methyl-^6desoxymophine).
1-Methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester, its salts and any preparation,
admixture, extract or other substance containing any proportion of l-methyl-4phenylpiperidine-4-carboxylic acid isopropyl ester.
Normethadone, its salts and any preparation, admixture, extract or other substance containing
any proportion of normethadone
Phenomorphan (3-hydroxy-N-phenethylmorphinan), its salts and any preparation, admixture,
extract or other substance containing any proportion of phenomorphan (3-hydroxy-Nphenethylmorphinan).
Propoxyphene (4-dimethylamino-l : 2-diphenyl-3-methyl-2-propionyloxybutane). its salts and
any preparation, admixture, extract or other substance containing any proportion of
propoxyphene (4-dimethylamino-l : 2-diphcnyl-3-methyl-2-propionyloxybutane).
Racemorphan, its salts and any preparation, admixture, extract or other substance containing
any proportion of racemorphan.
Declaration under section 14 (5)
It has been declared that findings with respect to the following preparations have, in
pursuance of Article .8 of the Geneva Convention (No. 1), been communicated to the parties
to that Convention and Part V of the Act ceases to apply to those preparations (a) MORPHINE PREPARATIONS
1. Cereoli iodoformi et
morphinae
2. Emplastrum opii
3. Emplastrum opii
4. Emplastrum opii
5. Emplastrum opii
6. Empiastrum opii (see
formula under 5)
Iodoform
Morphine hydrochloride
Oil of theobroma, sufficient to fill
a 1-gramme mould
Elemi
Terebinthina
Cera flava
Olibanum pulvis
Benzoes pulvis
Opii pulvis
Balsanum peruvianum
Extract of opium
Refined elemi
Diachylon plaster with gum
Elemi
Terebinthinoe communis
Cerae flavae
Olibani pulveratae
Benzoes pulveratae
Opii pulverati
Balsami peruviani
Opium, in very fine powder
Resin plaster
Mixed with other plasters
contained in
the British Pharmacop
In 1 bougie
0.320 grame
0.016 gramme
20 grammes
30
15
18
10
5
2
25
25
50
8
15
5
8
4
2
1 gramme
10 grammes
90
Rev. 1983]
7. Linimentum opii
8. Linimentum opii (see
formula under 7)
9. Linimentum opii
ammoniatum
10. Linimentum opii
ammoniatum (see
formula under 9)
11. Caustic “Nerve
Pastes”
12. Diarrhoea pills
13. Pilulae digitalis et
Opii compositae
14. Pilulae hydrargyri
cum Opio
15. Pilulae hydragyri
cum Creta et Opii
16. Pilulae ipecacuanha
cum Scilla
17. Pilulae hydrargyri
bichlorati cum Opii
extracto
18. Pilulae hydrargyri
iodati cum Opii pulvere
19. Pilula plumbi cum
Opio
20. Pilululae
Dangerous Drugs
Tincture of opium
Liniment of soap
Mixed with any other liniment of
the British Pharmacopoeia or of
the British Pharmaceutical
Codex.
Ammoniated liniment of
camphor 30
Tincture of opium .. 30
Liniment of belladonna .. 5
Strong solution of ammonia .. 5
Liniment of soap to .. .. 100
Mixed with any other British
Pharmaco-poeia or British
Pharmaceutical Codex
liniment
Preparations containing, in
addition to morphine salts, or
morphine and cocaine salts, at
least 25 per cent of arsenious
acid, and made up with the
requisite proportion of creosote
or phenol to produce the
consistency of a paste.
Camphor
Lead acetate
Bismuth subnitrate
Tannic acid
Opium power
Digitalis leaves, in powder
Opium, in power
Ipecacuanha root, in powder
Quinine sulphate
Syrum of glucose, a sufficient
quantity to make 12 pills
Mercury pill
Opium, in powder
To make 12 pills.
Compound powder of
ipecacuanhas*
Milk, sugar, a sufficient quandty
Syrup of glucose, a sufficient
quantity.
To make 12 pills
Compound powder of
ipecacuanhas*
Squill, in powder
Ammoniacum, in powder
Syrup of glucose, a sufficient
quantity.
Bichloride of Mercury triturated
Extract of opium
Extract of couch-grass
Liquorice root in powder,
quantity sufficient for 10 pills
Hydrargyrum iodatum freshly
prepared Opium powder
Powdered liquorice
White honey, quantity sufficient
for ten pills
Lead acetate, in powder
Opium, in powder
Syrup of glucose (or a sufficient
quantity)
Opium
Cap. 245
500 millilitres
500
0.0648 gramme
0.013
0.162
0.0648
0.026
0.31 gramme
0.19
0.13
0.78
3.89 grammes
0.19
0.78 gramme
0.78
30 grammes
10
10
10 centigrammes
20
20
50 centigrammes
20
30
80 grammes
12
8
0.5 gramme
33
34
Cap. 245
Terebinthinae
compositae
21. Pulvis ipecacuanhae
compositus Syn:
Pulvis ipecacuanhae et
Opii (Dover’s powder)
22. Mixtures of Dover’s
powder (see formula
ndeir 21)
23. Pubes lino
compositus
24. Suppositoria plumbi
compoita, Syn.:
Suppositoria
Plumbi cum Opio
25. Coryza Tablets No. 2
26. Diarrhoea Tablets
No. 2
27. Dysentery Tablets
28. Tabella hydrargyri
cum Opio
29. Tabella plumbi cum
Opio
30. Tablettae plumbi
cum Opio
31. Unguentum gallae
compositum
32. Unguentum gallae
compositum (see
formula under 31)
33. Unguetum gallae
cum Opio
Dangerous Drugs
Chinini sulfas
Styrax liquidus
Terebinthina laricina
Magnesii subcarbonas, a
sufficient quantity to make 100
pills
Ipecacuanha root, in powder
Opium, in powder
Potassium sulphate, in powder
With mercury and chalk,
aspirin, phenacetin, quinine and
its salts, and sodium
bicarbonate
Kino, in powder
Opium, in powder
Cinnamon bark, in powder .
Lead acetate, in powder
Opium in powder
Oil of theobroma, a sufficient
quantity for 12 suppositories,
each weighing about 1 gramme
Powered opium
Quinine sulph
Ammon. Chlor
Camphor
Ext. Belladonna leaves
Ext. aconite root
Powdered opium ..
Camphor ..
Powdered ipecacuanha
Lead acetate
Powdered opium
Powdered rpecacuanha
Powdered calomel
Lead acetate
Bismuth betanaphthol
Mercurous chloride powder
Antimony oxide powder
Ipecacurinha-root powder
Powdered opium
Milk sugar
Gelatine solution, a sufficient
20 „
quantity to make 1 tablet.
Sugar of lead
Powdered opium
Gelatine solution, a sufficient
quantity to make 1 tablet
Lead acetate, in fine powder
Opium, in powder
Refined sugar, in powder
Ethereal solution of theobroma
Alcohol
Galls in very fine powder .. 20
Extract of opium .. .. 4
Distilled water .. 16
Wool fat .. 10
Soft paraffin, yellow
Mixed with other ointments and
plasters contained in the British
Pharmacopoeia or British
Pharmaceutical Codex
Gall ointment
Opium in powder
[Rev. 1983
2 grammes
2
8
10 grammes
10
80
75 grammes,
5„
20
2.4
0.8
0.0043 gramme
0.022
0.022
0.022
0.0043
0.0043
0416
0-016
0.008
0.01
0413
0-0648
04324
04324
0.1944
0.065
0.065
0.065
0.065
0.065
0.195
0.065
19.44
3.24
6.48
3.60
0.90
92.5 grammes
7.5
Rev. 1983]
34. Unguentum gallae
cum Opio (see formula
under 33)
35. Yatren-105
(Iodooxyquinolinesulphonic acid)
1. Bernatzik’s Injections
3. Natrium biboracicum
compositum cum Cocaino
4. Caustic “Nerve Pastes”
5. Cocaine and Atropine
Tablets, with a content
of not more than 0.0003
gramme of cocaine salts
and not less than 0.0003
gramme of atropine salts
to each tablet
1. Elixir camphorae
compositum
2. Elixir diamorphinae et
Terpini, with
Apomorphine
3. Linctus diamorphinae
with Ipecacuanha
4. Linctus senegae
compositus
5. Linctus thymi
compositus
Dangerous Drugs
Mixed with other ointments and
plasters contained in the British
Pharmacopoeia or British
Pharmcopoeia or British
Pharmaceutical Codex
With 5 per cent opium
admixture
(b) COCAINE PREPARATIONS
(a) Hydrargyrum bicyanatum
0.03 gramme
Cocain= ..
0.02 „
(b) Hydrprgyrum succinatum
0.03 „
Cocainum
0.01
(a) Hydrargyrum succinaturn
0.03
Cocainum muriaticum
0.01
(b) Hydrargyrutrt succinatum
0.05
Cocainum muriaticum
0.03
In tablets, compressed tablets, lozenges, pastilles and ihe
like, difficult to break up, and containing not more than 0.2
per cent of cocaine salts in conjunction with not less than
20 per cent borax and not less than 20 per cent antipyrine,
or some similar analgesic, and not more tham 40 per cent
of flavouring matter. Maximuin weight of each tablet, etc.,
1 gramme.
Preparations containing, in addition to cocaine salts or
cocaine and morphine salts, at least 25 per cent of
arsenious acid, and made up with the requisite proportion
of creosote or phenol to produce the consistency of a
paste.
Atropinum sulphuric= ..
0.0003
Cocainum hydrochloricum Marmite 0.003
gramme
„
0.0003 „
0.003
Weight of one tablet ..
Cocaine content 8.3 per cent.
0.0036
gramme
(c) HEROIN PREPARATIONS
Camphor
4 grains
Oil of anise
5 minims
Benzoic acid ..
6 grains
Diamorphine hydrochloride
4
Liquid extract of ipecacuanha
120 minims
Tincture of squill.
1½ fl. ounces
Simple syrup to 20 fl. ounces.
Apomorphine hydrochloride ..
5 grains
Diamorphine hydrochloride
4
Terpin hydrate ..
44
Alcohol .. ,
10 fl. Ounces
Glycerine ..
5
Syrup of wild cherry to 20 fl. ounces.
Liquid extract of ipecacuanha
120 minims
Diamorphine hydrochloride
4 grains
Tincture of hyoscyamus
1 ½ fl. Ounces
Spirit of chloroform ..
1½ fl. Ounces
Syrup of balsam of tolu
3
Syrup of wild cherry ..
3
Glycerine to 20 fl. ounces.
Liquid extract of senega
1 fl ounce
Liquid extract of squill ..
1 ounce
Tartarated antimony ..
8 grains
Diamorphine hydrochloride
4 grains
Glycerine .. .
2 fl ounces
Simple syrup to 20 fl. ounces.
Diamorphine hydrochloride
4 grains
Apomorphine hydrochloride
5 grains
Cap. 245
35
36
Cap. 245
1. Cariazol-Dicodide
Solutions
1. Anti-Opium Tablets*
2. Tablets B.B Compound
Dangerous Drugs
Distilled water ..
Liquid extract of thyme (I-I)
Solution of tolu
Glycerine to 20 fl. ounces.
(d) DICODIDE PREPARATIONS
Solutions containing not less than 10 per
cent of cardiazol
and not more than 0.5 per cent of
dicodide salts.
(e) EUCODAL PREPARATIONS
Eucodal
Pulvis gentianae
Pulvis ipecacuatthae
Quinine rulphate
Caffeine
Sugar of milk
Mix up and make up 5-grain tablets.
Berberis vulgaris powder
Nux vomica
Eucodal
Ipecacuanha
Rhubarb
Pulvis cinnamon compositus
Aromatic chalk
[Rev. 1983
1 fl ounce
5 fl. Ounces
1¼
1 gramme
35 grammes
20 grammes
20 grammes
5 grammes
25 grammes
0.0324
gramme
0.013
0.0032
0.0648
0.013
0.0324
0.0032
*In exempting this preparation from the operation of the Geneva Convention, the Health
Committee expressed the wish that it should not be offered to the public under the name of
"anti-opium”